Given the emerging evidence of altered serum antibody repertoires targeting microbiome antigens (56) in ME/CFS patients, future studies should also consider sequencing IgA, as well as IgM and IgG isotypes. This evidence concerns the gene CD79A and myalgic encephalomeyelitis/chronic fatigue syndrome.